An underground economy for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.
Service Response and Content Removal
According to the social media company, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at home.
Within moments of entering one community, a vendor shared contact information, where the majority of purchases take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.
Item Information and Costs
Within these groups, messages show dark colored parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram stated it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has already seen patients harmed by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially serious medical dangers”.
